Reasons for (not) discontinuing antipsychotics in dementia

Publisher： John Wiley & Sons Inc

E-ISSN： 1479-8301|18|1|13-20

ISSN： 1346-3500

Source： Psychogeriatrics, Vol.18, Iss.1, 2018-01, pp. : 13-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Behavioural Problems Associated With Dementia: The Role of Newer Antipsychotics

By Stoppe G.   Brandt C.A.   Staedt J.H.  

Drugs & Aging, Vol. 14, Iss. 1, 1999-01 ,pp. : 41-54

Adis International

Access to resources Recommend Favorite

Alternatives to Atypical Antipsychotics for the Management of Dementia-Related Agitation

By Passmore Michael J.  

Drugs & Aging, Vol. 25, Iss. 5, 2008-01 ,pp. : 381-398

Adis International

Access to resources Recommend Favorite

Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

By  

Current Neuropharmacology, Vol. 6, Iss. 2, 2008-06 ,pp. : 117-124

Bentham Science Publishers

Access to resources Recommend Favorite

Withholding, Discontinuing and Withdrawing Medications in Dementia Patients at the End of Life: A Neglected Problem in the Disadvantaged Dying?

By Parsons Carole  

Drugs & Aging, Vol. 27, Iss. 6, 2010-06 ,pp. : 435-449

Adis International

Access to resources Recommend Favorite

Atypical Antipsychotics for Neuropsychiatric Symptoms of Dementia: Malignant or Maligned?

By Herrmann Nathan   Lanctôt Krista L.  

Drug Safety, Vol. 29, Iss. 10, 2006-01 ,pp. : 833-843

Adis International

Access to resources Recommend Favorite